Sekar Kathiresan, Chief Executive Officer at Verve Therapeutics, Inc. (VERV), sold 1,870 shares at $39.90 ($75K) on 2022-01-04, disclosed to the SEC on 2022-01-06.
Open-market sale of $75k VERV by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VERV | SELL | 2022-08-11 | $1.5M | — | Filing → |
| VERV | SELL | 2022-07-21 | $1.5M | — | Filing → |
| VERV | SELL | 2021-12-29 | $3.9M | — | Filing → |